Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2022-03-02 AGM Information
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal notification filed with the Korea Exchange (KRX) regarding the company's decision to hold its Annual General Meeting (AGM) on a date that coincides with the 'concentrated' shareholder meeting period. It explains the reasons for this scheduling and references the related AGM convocation notice. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2022-03-02 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the meeting preparation. Given it is a standard regulatory disclosure regarding corporate actions, it fits best under the RNS category.
2021-12-15 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification regarding the exercise of stock options (주식매수선택권 행사) by employees of the company. It details the number of shares exercised, the impact on total outstanding shares, the listing date for the new shares, and the remaining stock option balance. This type of filing relates to changes in capital structure due to the issuance of new shares resulting from option exercises, which falls under the 'Share Issue/Capital Change' category.
2021-12-09 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the share transactions (insider trading) of a specific executive (Park Ji-hoon) of the company 'Moogene Medi'. This falls under the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2021-11-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special related parties. This corresponds to the 'Major Shareholding Notification' category.
2021-11-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (Park Hyun-il) of the company 'Moogene Medi'. This is a standard regulatory filing for insider trading/director dealings in South Korea, which corresponds to the 'Director's Dealing' category.
2021-11-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.